Search

everythinglearnresearchcommunity

for

Search:↓

Using both PRP and minoxidil together works better for treating hair loss in men than using either one alone.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Low-level laser therapy can improve hair density in people with androgenic alopecia, but more research is needed to find out who it works best for.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Genetic factors could lead to personalized treatments for hair loss.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Minoxidil helps hair growth by activating enzymes in hair follicles.

Human platelets change minoxidil to minoxidil sulfate, helping blood vessels widen.

Minoxidil works in liver and outer hair root sheath for hair growth.

Minoxidil sulfotransferase is a marker of keratinocyte differentiation and may play a role in hair growth.

Minoxidil activates hair growth by being sulfated by P-PST in the human liver.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The enzyme PST is found in developing human kidneys and helps with detoxification and development.

Minoxidil helps treat pattern hair loss in both men and women.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.